Key result
Co-culture with cardiac progenitor cells attenuated the pro-fibrotic response of human fetal cardiac fibroblasts in a 3D hydrogel model, resulting in a 2.7-fold lower alpha-SMA expression (p=0.009).
Why the study?
Cardiac cell therapy may target fibroblast behavior in a paracrine fashion, but no reliable human fibrotic tissue model exists to evaluate this potential effect.
Does co-culture with cardiac progenitor cells reduce cardiac fibroblast activation and collagen synthesis in a 3D in vitro model of human cardiac fibrosis?
Does co-culture with cardiac progenitor cells reduce cardiac fibroblast activation and collagen synthesis in a 3D in vitro model of human cardiac fibrosis?
Effect estimate: 2.7-fold decrease
p-value: p=0.009
Cardiac progenitor cells attenuate pro-fibrotic signaling and collagen synthesis in human cardiac fibroblasts in a 3D in vitro model, suggesting a paracrine mechanism requiring continuous cross-talk.
Hypothesis-generating for paracrine anti-fibrotic effects of cardiac progenitor cells; in vivo studies required before clinical consideration.
Cardiac fibroblasts play a key role in chronic heart failure. The conversion from cardiac fibroblast to myofibroblast as a result of cardiac injury, will lead to excessive matrix deposition and a perpetuation of pro-fibrotic signaling. Cardiac cell therapy for chronic heart failure may be able to target fibroblast behavior in a paracrine fashion. However, no reliable human fibrotic tissue model exists to evaluate this potential effect of cardiac cell therapy. Using a gelatin methacryloyl hydrogel and human fetal cardiac fibroblasts (hfCF), we created a 3D in vitro model of human cardiac fibrosis. This model was used to study the possibility to modulate cellular fibrotic responses. Our approach demonstrated paracrine inhibitory effects of cardiac progenitor cells (CPC) on both cardiac fibroblast activation and collagen synthesis in vitro and revealed that continuous cross-talk between hfCF and CPC seems to be indispensable for the observed anti-fibrotic effect.
No takes yet. Share an insight, caveat, or question.
Gartner et al. (2019) studied Cardiac fibrosis. Cardiac progenitor cells (CPC) vs. No CPC co-culture (monoculture or HMEC control) was evaluated on alpha-SMA expression (cardiac fibroblast activation) (2.7-fold decrease, p=0.009). Co-culture with cardiac progenitor cells attenuated the pro-fibrotic response of human fetal cardiac fibroblasts in a 3D hydrogel model, resulting in a 2.7-fold lower alpha-SMA expression (p=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: